NP47827 Multiple Sclerosis Medicines
- Acheteur
- The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Publié
- 2026-10-26
- Échéance
- Non indiqué
- Sources
- UK_FTS
- Valeur
- 30403887.0 GBP
Description
La description est dans la langue de la source.
The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine
CPV: 33600000
Abonnement
Consultez gratuitement les aperçus. Les liens vers les avis officiels et leurs documents, les permis de construire et l’accès MCP personnel nécessitent un abonnement payant actif.
Lire